Cancer and neoplasms
Adult Myopia Market to Register Incremental Growth by 2032, Examines DelveInsight | Key Companies Working in the Market – ORA, LENZ Therapeutics, Glaukos, Santen, Cloudbreak, Nevakar, Eyenovia
Aug
New York, USA, Aug. 30, 2023 (GLOBE NEWSWIRE) — Adult Myopia Market to Register Incremental Growth by 2032, Examines DelveInsight | Key Companies Working in the Market – ORA, LENZ Therapeutics, Glaukos, Santen, Cloudbreak, Nevakar, Eyenovia
The dynamics of the adult myopia market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies.
DelveInsight’s Adult Myopia Market Insights report includes a comprehensive understanding of current treatment practices, adult myopia emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].
Key Takeaways from the Adult Myopia Market Report
- As per DelveInsight’s analysis, the adult myopia market is anticipated to grow at a significant CAGR by 2032.
- As per the DelveInsight estimates, in 2022, the total incident cases of Adult Myopia were found to be ~38,000 in the 7MM. The most number of Adult Myopia cases were found in Japan followed by the US.
- Globally leading adult myopia companies such as ORA, Inc., LENZ Therapeutics, Inc, Glaukos Corporation, Vyluma, Inc., Sydnexis, Inc., Ocumension limited, Santen Pharmaceutical, Cloudbreak therapeutics, Nevakar, Inc., Eyenovia, Stuart Therapeutics, Cellix Bio, JeniVision, Zhaoke Ophthalmology, and others are developing novel adult myopia drugs that can be available in the adult myopia market in the coming years.
- Some of the key therapies for adult myopia treatment include OT-101, Aceclidine+Brimonidine combination ophthalmic solution, Pilocarpine Ophthalmic Topical Cream, and others.
Discover which therapies are expected to grab the major adult myopia market share @ Adult Myopia Market Report
Adult Myopia Overview
Adult myopia, commonly known as nearsightedness, is a refractive error of the eye that causes distant objects to appear blurry while close objects can be seen clearly. Unlike childhood myopia, which often stabilizes as a person reaches adulthood, adult myopia can develop or progress later in life due to various factors. Several factors contribute to the development of adult myopia. Genetics plays a significant role, as having one or both parents with myopia increases the likelihood of its occurrence.
The symptoms of adult myopia are similar to those of myopia that develop during childhood. Common signs include difficulty seeing distant objects clearly, squinting to read signs or watch television, eyestrain, headaches, and the need to squint or partially close the eyelids to see clearly. Adults with myopia may find it challenging to drive, particularly at night, and may experience visual fatigue during activities that require focusing on distant objects for prolonged periods. A comprehensive eye examination by an optometrist or ophthalmologist is crucial for diagnosing adult myopia. The examination may include visual acuity tests, where the patient reads letters from a chart at various distances, and a refraction test to determine the exact prescription for corrective lenses.
Adult Myopia Epidemiology Segmentation
The adult myopia epidemiology section provides insights into the historical and current adult myopia patient pool and forecasted trends for the seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
The adult myopia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalent Population of Adult Myopia
- Prevalence of Myopic Choroidal Neovascularization
Download the report to understand which factors are driving adult myopia epidemiology trends @ Adult Myopia Epidemiological Insights
Adult Myopia Treatment Market
In recent years, the adult myopia treatment landscape has expanded with innovative approaches that go beyond conventional methods. One such approach is the use of prescription eye drops containing atropine or other medications that help relax the eye’s focusing mechanism and slow down myopia progression. These drops are gaining attention for their potential to effectively control the worsening of nearsightedness in adults.
Specialized contact lenses, known as multifocal or dual-focus contact lenses, have emerged as a promising option for managing adult myopia. These lenses provide different zones for near and distant vision, which can help reduce strain on the eyes and potentially slow down myopia progression. Additionally, certain contact lenses are designed with peripheral defocus, a concept aimed at manipulating the peripheral light entering the eye to deter the elongation of the eyeball, a key factor in myopia development. Advancements in refractive surgery techniques have also broadened the horizons for treating adult myopia. Procedures like LASIK (Laser-Assisted In Situ Keratomileusis) and PRK (Photorefractive Keratectomy) offer the possibility of permanent vision correction by reshaping the cornea. These surgical options can be particularly appealing to adults seeking freedom from glasses or contact lenses.
However, it’s important to emphasize that while these emerging adult myopia treatments hold promise, they may not be suitable for everyone. The choice of treatment should be made in consultation with an experienced eye care professional who can assess the individual’s eye health, lifestyle, and preferences. Moreover, adopting healthy visual habits, such as taking regular breaks from screens, spending time outdoors, and practicing the 20-20-20 rule (looking at something 20 feet away for 20 seconds every 20 minutes), can complement any chosen treatment and contribute to better long-term eye health.
To know more about adult myopia treatment, visit @ Adult Myopia Treatment Drugs
Key Adult Myopia Therapies and Companies
- OT-101: ORA, Inc.
- Aceclidine+Brimonidine combination ophthalmic solution: LENZ Therapeutics, Inc/ORA, Inc.
- Pilocarpine Ophthalmic Topical Cream: Glaukos Corporation
Learn more about the FDA-approved drugs for adult myopia @ Drugs for Adult Myopia Treatment
Adult Myopia Market Dynamics
The adult myopia market’s trajectory is shaped by a multitude of drivers and barriers that intricately interact to define its landscape. Rapid urbanization and a shift towards indoor-focused activities have intensified the prevalence of adult myopia. The proliferation of digital devices and prolonged screen exposure, both at work and at leisure, have become significant drivers, as they strain visual acuity and contribute to myopia development. Moreover, the lack of outdoor time and exposure to natural light, which has been linked to myopia prevention, adds to the growing myopia burden.
On the other hand, formidable barriers hinder the adult myopia market’s progression. Inadequate public awareness campaigns about myopia’s potential consequences may lead to delayed diagnosis and treatment, impeding effective management. The dearth of qualified eye care professionals, particularly in underserved regions, exacerbates this issue. Complexities in understanding the intricate interplay of genetic predispositions and environmental factors in myopia development present challenges in devising universally applicable interventions. Adherence to prescribed treatment regimens, such as specialized contact lenses or pharmaceutical interventions, can be compromised due to practical and behavioral factors, impacting the desired outcomes.
Socioeconomic constraints and disparities in healthcare infrastructure create additional barriers. Access to advanced diagnostic technologies and innovative treatments might be unevenly distributed, limiting effective myopia management. Overcoming these barriers requires a holistic approach that addresses public awareness, healthcare infrastructure enhancement, and the development of adaptable treatment strategies that consider diverse demographic, cultural, and economic contexts. By addressing both the driving forces and obstacles, stakeholders can collaboratively navigate the complexities of the adult myopia market and foster sustainable solutions for better eye health.
| Adult Myopia Report Metrics | Details |
| Study Period | 2019–2032 |
| Adult Myopia Report Coverage | 7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan] |
| Key Adult Myopia Companies | ORA, Inc., LENZ Therapeutics, Inc, Glaukos Corporation, Vyluma, Inc., Sydnexis, Inc., Ocumension limited, Santen Pharmaceutical, Cloudbreak therapeutics, Nevakar, Inc., Eyenovia, Stuart Therapeutics, Cellix Bio, JeniVision, Zhaoke Ophthalmology, and others |
| Key Adult Myopia Therapies | OT-101, Aceclidine+Brimonidine combination ophthalmic solution, Pilocarpine Ophthalmic Topical Cream, and others |
Scope of the Adult Myopia Market Report
- Therapeutic Assessment: Adult Myopia current marketed and emerging therapies
- Adult Myopia Market Dynamics: Attribute Analysis of Emerging Adult Myopia Drugs
- Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
- Unmet Needs, KOL’s views, Analyst’s views, Adult Myopia Market Access and Reimbursement
Discover more about adult myopia drugs in development @ Adult Myopia Clinical Trials
Table of Contents
| 1. | Adult Myopia Market Key Insights |
| 2. | Adult Myopia Market Report Introduction |
| 3. | Adult Myopia Market Overview at a Glance |
| 4. | Adult Myopia Market Executive Summary |
| 5. | Disease Background and Overview |
| 6. | Adult Myopia Treatment and Management |
| 7. | Adult Myopia Epidemiology and Patient Population |
| 8. | Patient Journey |
| 9. | Adult Myopia Marketed Drugs |
| 10. | Adult Myopia Emerging Drugs |
| 11. | Seven Major Adult Myopia Market Analysis |
| 12. | Adult Myopia Market Outlook |
| 13. | Potential of Current and Emerging Therapies |
| 14. | KOL Views |
| 15. | Unmet Needs |
| 16. | SWOT Analysis |
| 17. | Appendix |
| 18. | DelveInsight Capabilities |
| 19. | Disclaimer |
| 20. | About DelveInsight |
Related Reports
Adult Myopia Epidemiology
Adult Myopia Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted adult myopia epidemiology in the 7MM.
Myopia Market
Myopia Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key myopia companies such as Vyluma, Inc., Sydnexis, Inc., Ocumension limited, Santen Pharmaceutical, Cloudbreak therapeutics, Nevakar, Inc., Eyenovia, Stuart Therapeutics, Cellix Bio, JeniVision, Zhaoke Ophthalmology, among others.
Myopia Pipeline
Myopia Pipeline Insight – 2023 report provides comprehensive insights into pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key myopia companies involved, such as Vyluma, Inc., Sydnexis, Inc., Ocumension limited, Santen Pharmaceutical, Cloudbreak therapeutics, Nevakar, Inc., Eyenovia, Stuart Therapeutics, Cellix Bio, JeniVision, Zhaoke Ophthalmology, among others.
Myopia Progression Market
Myopia Progression Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key myopia progression companies such as Johnson & Johnson Vision Care Inc, Beijing Airdoc Technology Co., Ltd, Essilor International, Menicon Co., Ltd., SightGlass Vision Inc, Indizen Optical Technologies, S.L.U., Bausch & Lomb Incorporated, Coopervision Inc, among others.
Contact Lenses Market
Contact Lenses Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key contact lenses companies, including Alcon Inc, Cooper Vision Inc, Johnson & Johnson Vision, Bausch Health Companies Inc., HOYA Vision Care Company, Contamac, ZEISS Group, SynergEyes, Menicon Co., Ltd., Gelflex, Orion Vision Group, Solotica, medios, SEED CO. LTD, among others.
Other Trending Reports
Digestive System Fistula Market | Dementia With Diabetes Market | Leber’s Hereditary Optic Neuropathy Market | Pecoma Market | Adamantinoma Market | Pegfilgrastim Biosimilar Insight | Functional Constipation Market | DDR Defective Tumors Market | Nephrotic Syndrome Pipeline | Pelizaeus-Merzbacher Disease Market | Hepatic Impairment Market | Primary Ciliary Dyskinesia Market | Surgical Bleeding Market | Radiotherapy-Induced Oral Mucositis Market | Relapsed Chronic Lymphocytic Leukemia CLL Market | Galactosemia Market | Glabellar Lines Market | Homozygous Familial Hypercholesterolemia Market | HR Positive/ HER2 Negative Breast Cancer Market | Lebers Hereditary Optic Neuropathy LHON Market | Nonalcoholic Fatty Liver Disease NAFLD Market | Orthotic Devices Market | Polypoidal Choroidal Vasculopathy Market | Sporadic Inclusion Body Myositis Market | Warm Autoimmune Hemolytic Anemia Market | Acid Sphingomyelinase Deficiency ASMD Market | B-Cell Chronic Lymphocytic Leukemia Market | Coccidioidomycosis Market | Frontotemporal Dementia Pipeline | Granulomatosis With Polyangiitis Market | Malignant Pleural Mesothelioma Market | Nocturnal Enuresis Market | Postmyocardial Infarction Syndrome Market | Severe Acute Respiratory Syndrome Sars Coronavirus Infection Market | Typhoid Fever Market | Ventricular Dysfunction Market | Burkitt Lymphoma Market | Chronic Progressive Multiple Sclerosis Market | Emesis Market | Fenebrutinib Market | Gastric Neuroendocrine Tumors Market | Juvenile Rheumatoid Arthritis Market | Persistent Epithelial Defects Market | Post-Polycythemia Vera Myelofibrosis Market | Primary Mediastinal Large B-Cell Lymphoma Market | Spinocerebellar Ataxias Market | Systemic Inflammatory Response Syndrome Market | Triple Negative Breast Cancer Market | Visceral Pain Associated With GI Disorders Market | Adrenal Cortex Neoplasms Market | Adrenal Insufficiency Market | Artificial Lung Devices Market | Atopic Keratoconjunctivitis AKC Market | Autonomic Dysfunction Market | Bradycardia Treatment Devices Market | Bullous Pemphigoid Market | Cone Rod Dystrophy Market | Cutaneous Lupus Erythematosus Market | Cyclin-Dependent Kinase-Like 5 Deficiency Disorder Market | Dermal Regeneration Matrix Market | Heart Pump Devices Market | Hemiplegia Market | Hepatic Impairement Market | Immunologic Deficiency Syndrome Market | Implantable Infusion Pump Market | Menorrhalgia Market Size | Myocarditis Market | Myopia Treatment Devices Market | Ocular Hypertension Market
Related Healthcare Services
Healthcare Consulting
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect with us on LinkedIn|Facebook|Twitter
